- Conditions
- Carotid Artery Disease, Stroke
- Interventions
- Carotid filter, Carotid reversal of flow
- Procedure
- Lead sponsor
- Dallas VA Medical Center
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 1
- States / cities
- Dallas, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–54
of 54
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Carotid Stenosis
- Interventions
- Carotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS
- Procedure · Device · Other
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 35 Years to 100 Years
- Enrollment
- 2,486 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2025
- U.S. locations
- 154
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 112 more
- Conditions
- Carotid Artery Diseases, Stroke, Cerebral Arteriosclerosis
- Interventions
- WALLSTENT® Endoprosthesis™
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- Not listed
- Enrollment
- 747 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2007
- U.S. locations
- 50
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Mountain View, California + 41 more
- Conditions
- Atrial Fibrillation, Stroke
- Interventions
- WATCHMAN Left Atrial Appendage Closure Technology, Warfarin
- Device · Drug
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2014
- U.S. locations
- 58
- States / cities
- Gilbert, Arizona • Scottsdale, Arizona • La Jolla, California + 46 more
- Conditions
- Severe Symptomatic Calcified Native Aortic Valve Stenosis
- Interventions
- Cerebral Protection System-The SENTINEL System with TAVR, TAVR
- Device
- Lead sponsor
- Claret Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 363 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 14
- States / cities
- Los Angeles, California • Washington D.C., District of Columbia • Clearwater, Florida + 9 more
- Conditions
- Renal Stenting in the Treatment of Pts w/a High Grade Ostial Atherosclerotic Renal Lesion(s).
- Interventions
- Lumen Biomedical FiberNet Embolic Protection System
- Device
- Lead sponsor
- VIVA Physicians
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2008
- U.S. locations
- 1
- States / cities
- San Jose, California